Liquidia Corp (LQDA): Next-Year EPS Estimate 810.79%
As of 2026-11-12, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 810.79%. Featured in 4 EPS revision reports, most recently on 2026-05-19.
On 2026-11-11, analyst consensus for LQDA's next-year EPS growth shifted from 173.90% to 810.79% — a positive change of 636.89 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 155.02%.
What's Driving This
The available EPS revision data do not support an upgrade as the structural driver: analysts lowered LQDA’s next-year EPS growth estimate from 73.99% to 26.57% on 2026-10-01. With no recent headlines available to connect
Generated 2026-11-10 from news as of 2026-10-02
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 810.79%
- EPS growth this year
- 155.02%
- EPS next quarter (est)
- $1.08
- Last price
- $58.12
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 810.79% | 155.02% | $1.08 | $58.12 |
| 2026-11-11 | 810.79% | 155.02% | $1.08 | $55.21 |
| 2026-11-10 | 173.90% | 241.62% | $0.38 | $51.40 |
| 2026-10-02 | 26.57% | 441.00% | $0.87 | $27.99 |
| 2026-10-01 | 26.57% | 441.00% | $0.87 | $27.99 |
| 2026-09-30 | 73.99% | 475.84% | $0.88 | $30.26 |
| 2026-09-29 | 81.47% | 483.50% | $0.88 | $70.69 |
| 2026-09-28 | 81.47% | 483.50% | $0.88 | $73.67 |
| 2026-09-27 | 81.47% | 483.50% | $0.88 | $68.43 |
| 2026-09-25 | 81.47% | 483.50% | $0.88 | $68.43 |
| 2026-09-24 | 81.47% | 483.50% | $0.88 | $70.95 |
| 2026-09-23 | 81.47% | 483.50% | $0.88 | $67.49 |
| 2026-09-22 | 81.47% | 483.50% | $0.88 | $68.64 |
| 2026-09-21 | 81.47% | 483.50% | $0.88 | $66.43 |
| 2026-09-20 | 81.47% | 483.50% | $0.88 | $66.88 |
| 2026-09-18 | 81.47% | 483.50% | $0.88 | $66.88 |
| 2026-09-17 | 81.47% | 483.50% | $0.88 | $68.39 |
| 2026-09-16 | 81.47% | 483.50% | $0.88 | $68.45 |
| 2026-09-15 | 81.47% | 483.50% | $0.88 | $65.72 |
| 2026-09-14 | 81.47% | 483.50% | $0.88 | $65.31 |
| 2026-09-13 | 81.47% | 483.50% | $0.88 | $66.74 |
| 2026-09-11 | 81.47% | 483.50% | $0.88 | $66.74 |
| 2026-09-10 | 81.47% | 483.50% | $0.88 | $67.85 |
| 2026-09-09 | 81.47% | 483.50% | $0.88 | $69.12 |
| 2026-09-08 | 81.47% | 483.50% | $0.88 | $67.68 |
| 2026-09-07 | 81.46% | 483.50% | $0.88 | $68.66 |
| 2026-09-06 | 81.46% | 483.50% | $0.88 | $68.66 |
| 2026-09-04 | 81.46% | 483.50% | $0.88 | $68.66 |
| 2026-09-03 | 81.46% | 483.50% | $0.88 | $68.63 |
| 2026-09-02 | 81.46% | 483.50% | $0.88 | $69.68 |
Reports Featuring LQDA
Recent News
- Liquidia's Record YUTREPIA Quarter Is Overshadowed By A Settlement That Narrows The Label To PAH, Uses Most Of Its Cash, And Ends The $1B TargetEarnings Whispers
- Liquidia Corporation to Present at 2026 Jefferies Global Healthcare ConferenceGlobeNewswire
- Liquidia Corporation Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- CoreWeave headlines Tuesday's earnings slateMarketWatch
- Biotech Beats SPY And QQQ In Market Rout Now Hims Earnings And Summits FDA Test Take Center StageStocktwits
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Liquidia Corp's next-year EPS growth estimate?▾
As of 2026-11-12, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 810.79%, based on analyst consensus.
When was the latest EPS estimate revision for LQDA?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 173.90% to 810.79%.
What sector and industry does Liquidia Corp belong to?▾
Liquidia Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LQDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Liquidia Corp (LQDA) appears here because it was detected by our daily top-EPS-revision-performer screen.